Skip to content

Performance of Endoscopic Ultrasound in the Diagnosis of Fatty Pancreas

Performance of Endoscopic Ultrasound in the Diagnosis of Fatty Pancreas

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200902004
Enrollment
108
Registered
2020-09-02
Start date
2020-09-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diagnostic EUS Fatty Pancreas Pancreatic cancer Diagnostic EUS Fatty Pancreas Pancreatic cancer

Interventions

operative EUS in the same session of pancreatic surgery
Experimental Procedure/Surgery
Endoscopic ultrasound

Sponsors

Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor
Faculty of Medicine Siriraj Hospital&#44
Collaborator
Mahidol University,Faculty of Medicine Siriraj Hospital, Mahidol University
Collaborator

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patient who scheduled pancreaticoduodenectomy or distal pancreatectomy in Siriraj hospital

Exclusion criteria

Exclusion criteria: 1. Patient use drug induced visceral fatty accumulation such as amiodarone, steroid, methotrexate, sex hormone 2. Patient with high risk for EUS and surgery: bleeding tendency, unstable hemodynamics, severe cardiovascular disease

Design outcomes

Primary

MeasureTime frame
Diagnostic performance of EUS in fatty pancreas At the end of intervention Sensitivity, Specificity, PPV, NPV

Secondary

MeasureTime frame
Predictive factors of fatty pancreas At the end of intervention Odd ratio, p-value,Association between fatty pancreas and pancreatic cancer At the end of intervention Odd ratio, p-value

Countries

Thailand

Contacts

Public ContactNonthalee Pausawasdi

Faculty of Medicine, Siriraj Hospital

nonthaleep7@gmail.com6624197281

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026